Skip to content
10-Q

Quarterly Report

CHECKPOINT THERAPEUTICS, INC.

0001410578-25-001233

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2025 · Mar 31, 2025 59.82M sh
Shares Diluted Q1 2025 · Mar 31, 2024 32.93M sh
Shares Outstanding Q1 2025 · Mar 31, 2025 83.06M sh
Shares Outstanding Q1 2025 · Dec 31, 2024 53.64M sh
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$11.69M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$6.47M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $33.04M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $6.6M
Stockholders Equity Q1 2025 · Mar 31, 2025 $16.3M
Stockholders Equity Q1 2025 · Dec 31, 2024 −$12.63M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$10.25M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$13.05M
Current Liabilities Q1 2025 · Mar 31, 2025 $17.87M
Current Liabilities Q1 2025 · Dec 31, 2024 $20.1M
Total Liabilities Q1 2025 · Mar 31, 2025 $17.87M
Total Liabilities Q1 2025 · Dec 31, 2024 $20.1M
Current Assets Q1 2025 · Mar 31, 2025 $34.16M
Current Assets Q1 2025 · Dec 31, 2024 $7.47M
Total Assets Q1 2025 · Mar 31, 2025 $34.16M
Total Assets Q1 2025 · Dec 31, 2024 $7.47M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.19
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.33
Eps Basic Q1 2025 · Mar 31, 2025 −$0.19
Eps Basic Q1 2025 · Mar 31, 2024 −$0.33
Sga Expense Q1 2025 · Mar 31, 2025 $7.36M
Sga Expense Q1 2025 · Mar 31, 2024 $2.45M
Rd Expense Q1 2025 · Mar 31, 2025 $3.79M
Rd Expense Q1 2025 · Mar 31, 2024 $8.5M
Net Income Q1 2025 · Mar 31, 2025 −$11.21M
Net Income Q1 2025 · Mar 31, 2024 −$10.95M
Operating Income Q1 2025 · Mar 31, 2025 −$11.15M
Operating Income Q1 2025 · Mar 31, 2024 −$10.95M